XBiotech Inc.
XBIT
$2.92
-$0.06-2.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 19.55% | -28.20% | -56.90% | -41.22% | -23.18% |
| Total Depreciation and Amortization | 1.50% | 1.27% | 0.06% | -0.74% | -15.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.30% | 177.87% | 431.92% | 2,075.25% | 12.18% |
| Change in Net Operating Assets | -158.07% | -124.32% | -153.66% | -64.63% | 24.26% |
| Cash from Operations | -6.79% | -44.33% | -65.36% | -50.93% | -29.69% |
| Capital Expenditure | 44.95% | -87.07% | -260.22% | -252.24% | -85.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | 197.71% |
| Cash from Investing | -100.93% | -101.87% | -102.12% | -102.31% | 195.25% |
| Total Debt Issued | -97.50% | -97.50% | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -10.19% | 141.67% | 3,900.00% | 3,240.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 100.00% |
| Cash from Financing | -197.97% | -198.10% | 116,211.11% | 113,066.67% | 72,300.00% |
| Foreign Exchange rate Adjustments | 98.78% | -126.11% | -11,919.57% | -102.06% | -466.50% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -178.85% | -192.97% | -164.02% | -145.82% | 154.78% |